Novartis Scores Its First Tumor-Agnostic Label For Two Nearly Decade-Old Cancer Drugs

 
• By Alaric DeArment
  
Novartis is the latest company to win FDA approval in a tumor-agnostic cancer indication • Source: Shutterstock

More from New Products

More from Scrip